213 related articles for article (PubMed ID: 21807448)
1. Novel therapy to reverse the cellular effects of bisphosphonates on primary human oral fibroblasts.
Cozin M; Pinker BM; Solemani K; Zuniga JM; Dadaian SC; Cremers S; Landesberg R; Raghavan S
J Oral Maxillofac Surg; 2011 Oct; 69(10):2564-78. PubMed ID: 21807448
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of oral mucosal cell wound healing by bisphosphonates.
Landesberg R; Cozin M; Cremers S; Woo V; Kousteni S; Sinha S; Garrett-Sinha L; Raghavan S
J Oral Maxillofac Surg; 2008 May; 66(5):839-47. PubMed ID: 18423269
[TBL] [Abstract][Full Text] [Related]
3. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.
Pabst AM; Ziebart T; Koch FP; Taylor KY; Al-Nawas B; Walter C
Clin Oral Investig; 2012 Feb; 16(1):87-93. PubMed ID: 21225298
[TBL] [Abstract][Full Text] [Related]
4. The influence of geranylgeraniol on human oral keratinocytes after bisphosphonate treatment: An in vitro study.
Pabst AM; Krüger M; Ziebart T; Jacobs C; Sagheb K; Walter C
J Craniomaxillofac Surg; 2015 Jun; 43(5):688-95. PubMed ID: 25913629
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates affect migration ability and cell viability of HUVEC, fibroblasts and osteoblasts in vitro.
Walter C; Pabst A; Ziebart T; Klein M; Al-Nawas B
Oral Dis; 2011 Mar; 17(2):194-9. PubMed ID: 20796232
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonates inhibit cell functions of HUVECs, fibroblasts and osteogenic cells via inhibition of protein geranylgeranylation.
Hagelauer N; Ziebart T; Pabst AM; Walter C
Clin Oral Investig; 2015 Jun; 19(5):1079-91. PubMed ID: 25261400
[TBL] [Abstract][Full Text] [Related]
7. Effects of pamidronate on human alveolar osteoblasts in vitro.
Marolt D; Cozin M; Vunjak-Novakovic G; Cremers S; Landesberg R
J Oral Maxillofac Surg; 2012 May; 70(5):1081-92. PubMed ID: 21856057
[TBL] [Abstract][Full Text] [Related]
8. The influence of geranylgeraniol on microvessel sprouting after bisphosphonate substitution in an in vitro 3D-angiogenesis assay.
Pabst AM; Krüger M; Sagheb K; Ziebart T; Jacobs C; Blatt S; Goetze E; Walter C
Clin Oral Investig; 2017 Apr; 21(3):771-778. PubMed ID: 27170294
[TBL] [Abstract][Full Text] [Related]
9. Zoledronic acid and geranylgeraniol regulate cellular behaviour and angiogenic gene expression in human gingival fibroblasts.
Zafar S; Coates DE; Cullinan MP; Drummond BK; Milne T; Seymour GJ
J Oral Pathol Med; 2014 Oct; 43(9):711-21. PubMed ID: 24762323
[TBL] [Abstract][Full Text] [Related]
10. Comments on Novel Therapy to Reverse the Cellular Effects of Bisphosphonates on Primary Human Oral Fibroblasts by Cozin M et al (2011).
Ziebart T; Walter C
J Oral Maxillofac Surg; 2012 Jan; 70(1):3. PubMed ID: 22182654
[No Abstract] [Full Text] [Related]
11. Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis.
Scheper MA; Badros A; Chaisuparat R; Cullen KJ; Meiller TF
Br J Haematol; 2009 Mar; 144(5):667-76. PubMed ID: 19036117
[TBL] [Abstract][Full Text] [Related]
12. Influence of bisphosphonates on endothelial cells, fibroblasts, and osteogenic cells.
Walter C; Klein MO; Pabst A; Al-Nawas B; Duschner H; Ziebart T
Clin Oral Investig; 2010 Feb; 14(1):35-41. PubMed ID: 19294435
[TBL] [Abstract][Full Text] [Related]
13. Geranylgeraniol - a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw.
Ziebart T; Koch F; Klein MO; Guth J; Adler J; Pabst A; Al-Nawas B; Walter C
Oral Oncol; 2011 Mar; 47(3):195-201. PubMed ID: 21247791
[TBL] [Abstract][Full Text] [Related]
14. PRGF exerts a cytoprotective role in zoledronic acid-treated oral cells.
Anitua E; Zalduendo M; Troya M; Orive G
Clin Oral Investig; 2016 Apr; 20(3):513-21. PubMed ID: 26201455
[TBL] [Abstract][Full Text] [Related]
15. Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: a case-control study.
Wessel JH; Dodson TB; Zavras AI
J Oral Maxillofac Surg; 2008 Apr; 66(4):625-31. PubMed ID: 18355585
[TBL] [Abstract][Full Text] [Related]
16. Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice.
Kobayashi Y; Hiraga T; Ueda A; Wang L; Matsumoto-Nakano M; Hata K; Yatani H; Yoneda T
J Bone Miner Metab; 2010 Mar; 28(2):165-75. PubMed ID: 19882100
[TBL] [Abstract][Full Text] [Related]
17. Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.
Otto S; Pautke C; Opelz C; Westphal I; Drosse I; Schwager J; Bauss F; Ehrenfeld M; Schieker M
J Oral Maxillofac Surg; 2010 Nov; 68(11):2837-45. PubMed ID: 20971371
[TBL] [Abstract][Full Text] [Related]
18. The effects of platelet-derived growth factor-BB on periodontal cells in an in vitro wound model.
Mumford JH; Carnes DL; Cochran DL; Oates TW
J Periodontol; 2001 Mar; 72(3):331-40. PubMed ID: 11327060
[TBL] [Abstract][Full Text] [Related]
19. Bisphosphonate-induced osteonecrosis of the jaws: prospective study of 80 patients with multiple myeloma and other malignancies.
Boonyapakorn T; Schirmer I; Reichart PA; Sturm I; Massenkeil G
Oral Oncol; 2008 Sep; 44(9):857-69. PubMed ID: 18282788
[TBL] [Abstract][Full Text] [Related]
20. Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro.
Ziebart T; Pabst A; Klein MO; Kämmerer P; Gauss L; Brüllmann D; Al-Nawas B; Walter C
Clin Oral Investig; 2011 Feb; 15(1):105-11. PubMed ID: 20024592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
